Fig. 4From: Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysisOdds of all-cause discontinuation (FE model)Back to article page